-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, the country's efforts to rectify the environmental protection of the pharmaceutical industry have been increasing, and a series of documents have been issued
.
In this regard, the industry believes that under the influence of many environmental protection policies, the pharmaceutical industry will face increasingly severe environmental pressures.
If effective governance is not carried out, the high-quality development of the enterprise may be a very big obstacle
.
It is understood that in the context of increasingly stringent environmental protection, a large number of pharmaceutical companies have been punished for failing to meet environmental protection standards, including production restrictions or suspension of production for rectification
.
According to incomplete statistics, 17 pharmaceutical companies have been punished for environmental protection violations in 2021: 2 pharmaceutical companies sold hazardous waste to unqualified companies/persons for disposal, 8 pharmaceutical companies discharged waste gas/wastewater, 3 A pharmaceutical company's environmental protection facilities were put into production without acceptance.
.
.
Among them, many companies were fined one after another.
For example, a Northeast Pharmaceutical company received 8 fines
.
Specifically, since May, the company and its subsidiaries have been "named" by the eco-environmental supervision department every month and received 8 environmental fines, of which 7 were directly punished by the company
.
It should be noted that the company also received 4 environmental fines last year, and the number of existing fines doubled this year
.
In the context of China's promotion of green development and sustainable development, the industry generally believes that only by attaching great importance to the severe practical problems of pharmaceutical environmental protection and taking action can pharmaceutical companies achieve better development
.
Among them, compliance will be the foundation for the future survival and development of enterprises.
Only by shifting from brutal growth to compliance and green development can we better respond to changes in the industry
.
At present, in order to cope with the increasingly stringent environmental protection industry status, many companies have actually begun to invest heavily in treatment and remediation
.
As mentioned above, Northeast Pharmaceutical started in the fourth quarter of last year.
With the improvement of national pollution control standards, on the basis of previous environmental protection, another investment of 340 million yuan was carried out to carry out environmental protection improvement projects covering waste gas, wastewater and comprehensive utilization
.
As of the end of November this year, the project has entered the final stage
.
In addition, since 1995, pharmaceutical companies have invested more than 400 million yuan in the construction of sewage treatment plants alone.
.
Up to now, the pharmaceutical company has invested more than 1.
6 billion yuan in environmental protection infrastructure, of which the environmental protection operating expenses in 2019 reached 240 million yuan
.
In addition, some pharmaceutical companies have also invested 1 billion yuan to build environmental protection projects by introducing new environmental protection technologies and technologies, improving environmental protection hardware supporting facilities
.
It is reported that through the scientific construction of the energy system and environmental protection management system, the company’s environmental management level has been continuously improved.
The company’s wastewater, boiler exhaust gas and incinerator exhaust gas have all installed online monitoring systems to achieve up-to-standard emissions, and the emission concentration of major pollution factors is much lower than Standard requirements
.
Generally speaking, with the successive introduction of a series of environmental protection policies, the environmental protection storm in the industry has struck
.
As the pharmaceutical industry is a major energy consumer and a high-polluting industry, it is imperative to promote the innovation, application and development of green environmental protection technologies in the era of low-carbon economy and green environmental protection
.
In the future, pharmaceutical companies need to pay more attention to the concept of environmental protection, strengthen environmental protection rectification, eliminate outdated production capacity in time, introduce new environmental protection technology and devices, and take the road of sustainable development, in order to continuously demonstrate their strength and charm, and help the entire pharmaceutical industry to accelerate economic development A "win-win" situation with environmental protection
.
.
In this regard, the industry believes that under the influence of many environmental protection policies, the pharmaceutical industry will face increasingly severe environmental pressures.
If effective governance is not carried out, the high-quality development of the enterprise may be a very big obstacle
.
It is understood that in the context of increasingly stringent environmental protection, a large number of pharmaceutical companies have been punished for failing to meet environmental protection standards, including production restrictions or suspension of production for rectification
.
According to incomplete statistics, 17 pharmaceutical companies have been punished for environmental protection violations in 2021: 2 pharmaceutical companies sold hazardous waste to unqualified companies/persons for disposal, 8 pharmaceutical companies discharged waste gas/wastewater, 3 A pharmaceutical company's environmental protection facilities were put into production without acceptance.
.
.
Among them, many companies were fined one after another.
For example, a Northeast Pharmaceutical company received 8 fines
.
Specifically, since May, the company and its subsidiaries have been "named" by the eco-environmental supervision department every month and received 8 environmental fines, of which 7 were directly punished by the company
.
It should be noted that the company also received 4 environmental fines last year, and the number of existing fines doubled this year
.
In the context of China's promotion of green development and sustainable development, the industry generally believes that only by attaching great importance to the severe practical problems of pharmaceutical environmental protection and taking action can pharmaceutical companies achieve better development
.
Among them, compliance will be the foundation for the future survival and development of enterprises.
Only by shifting from brutal growth to compliance and green development can we better respond to changes in the industry
.
At present, in order to cope with the increasingly stringent environmental protection industry status, many companies have actually begun to invest heavily in treatment and remediation
.
As mentioned above, Northeast Pharmaceutical started in the fourth quarter of last year.
With the improvement of national pollution control standards, on the basis of previous environmental protection, another investment of 340 million yuan was carried out to carry out environmental protection improvement projects covering waste gas, wastewater and comprehensive utilization
.
As of the end of November this year, the project has entered the final stage
.
In addition, since 1995, pharmaceutical companies have invested more than 400 million yuan in the construction of sewage treatment plants alone.
.
Up to now, the pharmaceutical company has invested more than 1.
6 billion yuan in environmental protection infrastructure, of which the environmental protection operating expenses in 2019 reached 240 million yuan
.
In addition, some pharmaceutical companies have also invested 1 billion yuan to build environmental protection projects by introducing new environmental protection technologies and technologies, improving environmental protection hardware supporting facilities
.
It is reported that through the scientific construction of the energy system and environmental protection management system, the company’s environmental management level has been continuously improved.
The company’s wastewater, boiler exhaust gas and incinerator exhaust gas have all installed online monitoring systems to achieve up-to-standard emissions, and the emission concentration of major pollution factors is much lower than Standard requirements
.
Generally speaking, with the successive introduction of a series of environmental protection policies, the environmental protection storm in the industry has struck
.
As the pharmaceutical industry is a major energy consumer and a high-polluting industry, it is imperative to promote the innovation, application and development of green environmental protection technologies in the era of low-carbon economy and green environmental protection
.
In the future, pharmaceutical companies need to pay more attention to the concept of environmental protection, strengthen environmental protection rectification, eliminate outdated production capacity in time, introduce new environmental protection technology and devices, and take the road of sustainable development, in order to continuously demonstrate their strength and charm, and help the entire pharmaceutical industry to accelerate economic development A "win-win" situation with environmental protection
.